Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing ...

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ...

Although the importance of fertility preservation is widely recognized, there is a need for up-to-date evidence-based ...

Dr Emma Bolderson, from QUT's School of Biomedical Sciences, has received a $460,552 grant from the Ovarian Cancer Research ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

“We need to define the role of risk-reduction surgery in reducing tubo-ovarian cancer risk for non-BRCA gene mutations to balance the benefit of cancer risk reduction with the risks associated ...